As consumer awareness and regulatory scrutiny intensify, baby and infant product manufacturers face growing litigation over alleged trace contaminants such as PFAS, lead, benzene, and microplastics.

Join Baby Safety Alliance Associate Member Greenberg Traurig, LLP on Tuesday, October 6, 2026 at 2 p.m. ET as they examine how these claims blur the lines between traditional products liability and toxic tort doctrines, particularly where exposure levels are low, science is evolving, and causation is contested.

Panelists will discuss recent litigation trends, emerging plaintiff theories—including failure to warn, design defect, and consumer fraud—and the challenges courts face in evaluating scientific evidence, dose-response thresholds, and regulatory standards.

The session will also address defense strategies and proactive risk mitigation, including supply-chain management, product testing, and labeling considerations.

Designed for in-house counsel, litigators, and risk professionals, this panel offers practical guidance for navigating a rapidly developing, high-stakes area at the intersection of science, regulation, and litigation.